Thermo Fisher Scientific INC Form 4 insider transactions

Executive Vice President Frederick M. Lowery reports acquisition of shares and options in Thermo Fisher Scientific following the satisfaction of performance criteria for a restricted stock unit award.

Executive Vice President Michael D. Shafer of Thermo Fisher Scientific reports the acquisition of common stock and stock options related to performance-based restricted stock units.

Stephen Williamson, Sr. VP and CFO of Thermo Fisher Scientific, reports the acquisition of common stock and stock options, including vesting of performance-based restricted stock units.

Director Karen S. Lynch reports acquisition and disposal of Thermo Fisher Scientific Inc. common stock.

Thermo Fisher Scientific's CEO, Marc Casper, reported the disposal of 2,750 shares of common stock on February 14, 2025.

Gianluca Pettiti, an Executive Vice President at Thermo Fisher Scientific, sold 300 shares of common stock at a price of $585.59 per share on February 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Stephen Williamson, CFO of Thermo Fisher Scientific, exercised stock options and sold shares of common stock on February 3rd and 4th, 2025, according to a recent SEC Form 4 filing.

Jennifer M. Johnson, a director at Thermo Fisher Scientific, acquired phantom stock units under the company's Deferred Compensation Plan for Directors.

Scott M. Sperling, a director of Thermo Fisher Scientific, reported the acquisition of stock units under the company's Deferred Compensation Plan for Directors.

Director R. Alexandra Keith reports acquisition of phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Director Dion J. Weisler acquired 72.08 phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Thermo Fisher Scientific's SVP and General Counsel, Michael A. Boxer, reported a gift of 190 common shares to a donor-advised fund.

Thermo Fisher Scientific's CEO, Marc Casper, sold a total of 20,449 shares of common stock over two days, December 2nd and 3rd, 2024, under a pre-arranged 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, executed multiple sales of common stock on November 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, executed multiple sales of company stock on November 6th and 7th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on November 1, 2024, according to a pre-arranged Rule 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on October 28 and 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael A. Boxer, SVP and General Counsel of Thermo Fisher Scientific, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Executive Vice President Gianluca Pettiti of Thermo Fisher Scientific sold 300 shares of common stock at a price of $560.16 per share on October 25, 2024, according to a Form 4 filing.

Director Dion J. Weisler reports acquisition of phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Director R. Alexandra Keith acquired additional phantom stock units in Thermo Fisher Scientific through the company's Deferred Compensation Plan for Directors.

Director Jennifer M. Johnson reports acquisition and disposal of phantom stock units in Thermo Fisher Scientific Inc. under the company's Deferred Compensation Plan for Directors.

Director Scott Sperling reports acquisition of phantom stock units and disposal of common stock units under Thermo Fisher Scientific's Deferred Compensation Plan for Directors.

Thermo Fisher Scientific's CEO, Marc N. Casper, exercised stock options and sold shares of common stock on September 3rd and 4th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific, reported the disposal of common stock to cover tax obligations.

Stephen Williamson, Sr. VP and CFO of Thermo Fisher Scientific, reported the disposal of common stock to cover tax obligations.

Michael D. Shafer, an Executive Vice President at Thermo Fisher Scientific, reported the disposal of common stock to cover tax obligations.

Executive Vice President of Thermo Fisher Scientific, Gianluca Pettiti, reports disposing of common stock to cover tax obligations.

Executive Vice President and COO of Thermo Fisher Scientific, Michel Lagarde, reports the disposal of common stock to cover tax obligations.